Merck, Endocyte Withdraw Ovarion Cancer Drug Marketing Applications

Merck and Endocyte said Monday the companies have withdrawn conditional marketing authorization applications from the European Medicines Agency for an ovarian-cancer treatment.



from WSJ.com: US Business http://ift.tt/1j43RlH

via IFTTT